The Markets in Financial Instruments Directive (MiFID) is a regulatory framework that aims to increase investor protection and reduce systemic risk by setting common standards and rules for investment firms operating in the EU. It covers virtually all aspects of financial investment and trading in the EU.
MiFID II governs the provision of investment services in financial instruments. It applies to investment firms, wealth managers, broker dealers, product manufacturers and credit institutions authorised to carry out MiFID activities.
As a licensed and regulated service provider, as per Section 126.² Part 1 of the Financial Instrument Market Law, Dukascopy Europe IBS AS must ensure that clients have sufficient experience and knowledge in the investment field in relation to the particular investment service or product offered or requested. To meet this requirement, clients are asked to complete an assessment that checks whether the trading instruments offered by Dukascopy Europe IBS AS are appropriate to their profile.
The Appropriateness test is offered to clients prior to accessing their trading account for the first time, at the stage when they are asked to set up their permanent password. It consists of a set of questions that cover the client’s investment experience and investment knowledge.
After the completion of the test, its results are communicated to the client, concluding if the trading instruments offered by Dukascopy IBS AS (Contracts for Difference (CFDs) on 7 types of underlyings) are appropriate to the client’s knowledge and experience. If, on the basis of the information obtained, Dukascopy Europe considers that the instruments are not appropriate to the client, in accordance with Section 126.² Part 10 of the Financial Instrument Market Law it warns the client accordingly. The results of the test, together with the conclusions, remain always available to the client in the “My Documents” section of the Trader Cabinet.
Key information documents (KIDs) provide concise information about the main features of an investment product in a standardized consumer-friendly format. This includes the risk and reward profile and the costs associated with the product.
These are the result of the Packaged Retail and Insurance-based Investment Products (PRIIPs) regulation that aims to increase the efficiency of EU markets by helping investors to better understand and compare the key features, risk, rewards, and costs of different PRIIPs, through access to a short and consumer-friendly Key Information Document.
The Key Information Documents for the trading instruments offered by Dukascopy Europe IBS AS can be found on this dedicated website section.
AEOI aims at ensuring declaration of accounts to tax authorities.
It requires Latvian financial institutions to report information annually about certain accounts to the Latvian State Revenue Service (SRS). Concerned accounts are those held by natural persons or legal entities which are tax residents in the European Union or in a country with which Latvia has signed an agreement on AEOI (partner state). In case of accounts held by entities, under certain circumstances, the duty to report may concern also the person(s) controlling the entities.
After receiving this information, the SRS transfers it to the tax authority of the partner state(s) in which the concerned individual or entity has tax residence. If an individual or entity has tax residence in several partner states, FTA will communicate account information to each of these states.
The list of partner states can be found at https://likumi.lv/ta/id/279206-kartiba-kada-finansu-iestade-izpilda-finansu-kontu-pienacigas-parbaudes-proceduras-un-sniedz-valsts-ienemumu-dienestam
The reported account information includes the name, address, country of tax residence, tax identification number, date and place of birth/date of incorporation of the person or entity, as well as the account number and the account balance at the end of the reportable year. In the case of legal entity accounts, the reporting obligation may apply not only to the legal entity, but also to the legal entity's beneficial owner(s) and/or controlling person(s).
Dukascopy Europe offers LIVE trading on MetaTrader 4 and MetaTrader 5 platform with direct access to the SWFX Swiss Marketplace. Clients of the Dukascopy Europe can trade in both mobile and desktop versions of MetaTrader 4 and MetaTrader 5.
Please note the following important differences in trading conditions between MetaTrader and JForex accounts:
For more information, see the full specifications on MT4/MT5 accounts.
Depending on the services which Dukascopy Europe IBS AS provides to the client, various commissions may apply. Please consult the complete fee schedule published on our website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71.59% of retail investor accounts lose money when trading CFDs with this provider. Show more You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Show less